SLC7A5 and cancer: In this paper, by analyzing the relationship between SLC7A5 and cancer immune cycle, immunomodulators, TIIC, TIIC effectors and immune checkpoints, it was shown that SLC7A5 was significantly associated with inflammatory immune microenvironment and the patients with high SLC7A5 were more sensitive to immunotherapy.